M. Jimenez-Linan

Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay.

M. Rubin, A. Wyatt, H. Beltran, 2022, NAR cancer.

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

S. Tavaré, M. Loda, A. Tutt, 2021, Cancer cell.

Primary neuroendocrine carcinoma of the Bartholin's gland: Magnetic resonance imaging findings with pathologic correlation

E. Sala, H. Addley, R. Crawford, 2010 .

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

A. Tutt, C. Caldas, E. Provenzano, 2023, Nature communications.

7P Integration of whole genome sequencing (WGS) into NHS pathways for high-grade ovarian cancer (HGOC): A single-centre prospective experience

J. Brenton, A. Sosinsky, M. Ridley, 2023, ESMO Open.